Explanation
CorpulmonaleandowPO2
TheNationatInstituteforHealthandCareExcellence NCE) statesthatthefollowingare indicationsfor
considerinqlong-term oxygen therapy (LTOT);
StablepatientswithaPaO2of<73kPawhen stable
PatientswthaPaO.of7.3-8.0kPawhoarestablebutwhohavean additionauriskfactore.g.
secondarypolycythaemia,nocturnau hypoxaemia,peripheratoedema,pulmonary hypertension)
Oxvygen shouldbeusedforatleast15hperdayv.
@1MINENDOCRINE
